News & Updates
Lower Respiratory Tract Infections (LTRI) including Community-acquired Pneumonia (CAP) was the 4th leading cause of death in the world in 2012 according to the World Health organization (WHO). This is particularly relevant in lower income countries where LRTI are the number 1 cause of death with 91 deaths per 100 000 population. This is of particular importance in South Africa with a high HIV prevalence rate. LRTI are 25 times more common in the HIV population than the general population.
Furthermore, Medscheme has identified CAP as an emerging risk. Pneumonia also ranked as one of the top two conditions for GP-driven hospital-admissions for Bonitas Medical Scheme in all nine provinces.
There is a clear need to better understand CAP & LRTI, its aetiology, management and prevention
Read the full article here:
Randomized Dose-Ranging Study of the 14-Day Early Bactericidal Activity of Bedaquiline (TMC207) in Patients with Sputum Microscopy Smear-Positive Pulmonary Tuberculosis
New antimycobacterial compound PA 824 show promise in early Phase 2 study in the treatment of tuberculosis
Prof Andreas H Diacon MD [Corresponding Author] , Rodney Dawson MD, Florian von Groote-Bidlingmaier MD, Gregory Symons MBChB, Amour Venter NatDipTech, Prof Peter R Donald MD, Christo van Niekerk MD, Daniel Everitt MD, Helen Winter PhD, Piet Becker PhD, Carl M Mendel MD, Melvin K Spigelman MD
Published Online: 23 July 2012, Viewed May 2013, http://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2812%2961080-0/abstract